Myxobacterial depsipeptide chondramides interrupt SARS-CoV-2 entry by targeting its broad, cell tropic spike protein.
Published in "J Biomol Struct Dyn. (in press)."
R.A.Fernandez, M.T.Quimque, K.I.Notarted, J.A.Manzanoa, D.Y.Pilapil, V.N.de Leon, J.J.S.Josea, O.Villalobosf, N.H.Muralidharan, M.Michael Gromiha, S.Brogi, A.P.G.Macabeoa
